5Indexed trials
drug · Product Intelligence
Cyclophosphamide
Pipeline Intelligence
Cyclophosphamide: 5 indexed trials, 2 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
10FDA-linked events
Development evidence
NCT02601313Kite, A Gilead Company · out_of_scopePHASE2
NCT02622074Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT05008224Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06966700Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT07304154Kite, A Gilead Company · multiple_sclerosisPHASE1
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCYCLOPHOSPHAMIDE · 2024-10-29
FDA_APPROVALCYCLOPHOSPHAMIDE · 2023-09-12
FDA_APPROVALCYCLOPHOSPHAMIDE · 2023-07-17
FDA_APPROVALCYCLOPHOSPHAMIDE · 2019-01-18
FDA_APPROVALCYCLOPHOSPHAMIDE · 2018-05-07
FDA_APPROVALCYCLOPHOSPHAMIDE · 2014-10-31
FDA_APPROVALCYCLOPHOSPHAMIDE · 2013-09-16
FDA_APPROVALNEOSAR · 1993-04-29
FDA_APPROVALCYCLOPHOSPHAMIDE · 1986-09-24
FDA_APPROVALCYCLOPHOSPHAMIDE · 1986-07-03
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.